ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1012

Analysis of microRNAs in Familial Mediterranean Fever

Gil Amarilyo1, Nir Pillar2, Ilan Ben-Zvi3, Daphna Weissglas-Volkov2, Jonatan Zalcman2, Liora Harel4, Avi Livneh3 and Noam Shomron2, 1Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel, 2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 4Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: MicroRNA and familial Mediterranean fever

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 6, 2017

Session Title: Genetics, Genomics and Proteomics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Familial Mediterranean fever (FMF) is thought to be inherited as an autosomal recessive trait. However, there are frequent deviations from this model. The aim of this study was to explore epigenetic modifications in patients with FMF.

Methods: Ten patients diagnosed with FMF according to the Tel-Hashomer criteria were recruited from the rheumatology outpatient clinic of Sheba Medical Center, Tel Hashomer, Israel. All patients were homozygous for the M694V mutation, the most common mutation in FMF, and all had the most severe phenotype of the disease. All were in the quiescent phase at the time of the study. Total RNA was drawn from peripheral blood and profiled for microRNA expression using NanoString nCounter technology. Findings were compared to 10 healthy age- and sex-matched control subjects. Statistical analyses were conducted using R software, version 3.2. Data preprocessing and normalization followed by differential expression analysis were performed using the R package DESeq2 (25516281) and in house scripts. A priori P values were adjusted for false discovery rate (FDR).

Results: Of the 798 mature human miRNAs probed, 103 exhibited reasonable expression levels in these cells. Seven were found to be significantly deregulated in the patients with FMF: three were significantly downregulated compared to control samples (miR-107, let−7d−5p, and miR-148b-3p), and four were significantly upregulated (miR-144-3p, miR-21−5p, miR−4454 and miR-451a), all with an adjusted P value of  <0.01 (Figure 1).

To ensure that the observed changes were true biological effects and not technical artifacts, we performed Taqman quantitative real time polymerase chain reaction (qRT-PCR) analysis of two of the differentially expressed miRNAs between the patients and controls. Each miRNA was quantified in each sample, and its expression level was normalized to the reference RNA, U6-snRNA. In both groups, the direction of effect and the miRNA expression patterns in the NanoString analysis were consistent with the Taqman measurements (R2=0.93)

Conclusion: We identified significant epigenetic changes in patients with clinically quiescent FMF. Further research is warranted in order to elucidate critical FMF manifestation such as susceptibility to early disease, disease severity, risk of the development of amyloidosis, and resistance to colchicine. All these factors might be ultimately explained, at least in part, by epigenetic modifications.

                                                                       

 

 

Figure 1

 


Disclosure: G. Amarilyo, None; N. Pillar, None; I. Ben-Zvi, None; D. Weissglas-Volkov, None; J. Zalcman, None; L. Harel, None; A. Livneh, None; N. Shomron, None.

To cite this abstract in AMA style:

Amarilyo G, Pillar N, Ben-Zvi I, Weissglas-Volkov D, Zalcman J, Harel L, Livneh A, Shomron N. Analysis of microRNAs in Familial Mediterranean Fever [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/analysis-of-micrornas-in-familial-mediterranean-fever/. Accessed January 20, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-micrornas-in-familial-mediterranean-fever/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.